AbbVie | ABBV - Stock

Stock Price
209.53
Daily Change
-1.79 -0.85%
Monthly
0.33%
Yearly
5.57%
Q2 Forecast
194.46

AbbVie reported $4.95B in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
Abbott USD 6.99B 501M Mar/2026
ALKERMES USD 196.62M 5.63M Dec/2025
Amgen USD 6.19B 39M Mar/2026
AstraZeneca USD 6.57B 13M Mar/2026
Biogen USD 1.95B 219.1M Mar/2026
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Coherus Biosciences USD 3.17M 1.12M Dec/2025
Eisai JPY 236.46B 9.14B Sep/2025
Eli Lilly USD 14.53B 785M Mar/2026
Gilead Sciences USD 1.77B 11M Dec/2025
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Infinity Pharmaceuticals USD 0 0 Sep/2021
J&J USD 14.58B 392M Mar/2026
Medtronic USD 6.31B 153M Dec/2025
Merck USD 6.66B 214M Dec/2025
Neurocrine Biosciences USD 69M 300K Dec/2025
Novartis USD 6.27B 152M Dec/2025
Pacira USD 150.37M 2.49M Mar/2026
Perrigo USD 1.15B 78M Dec/2025
Pfizer USD 11.47B 201M Sep/2025
Regeneron Pharmaceuticals USD 3.1B 97.2M Mar/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025
UCB EUR 1.31B 173M Dec/2024
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
United Therapeutics USD 183.1M 6.6M Dec/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025
Zoetis USD 2.43B 35M Dec/2025